Tabula Rasa HealthCare
Stock Forecast, Prediction & Price Target
Tabula Rasa HealthCare Financial Estimates
Tabula Rasa HealthCare Revenue Estimates
Tabula Rasa HealthCare EBITDA Estimates
Tabula Rasa HealthCare Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $297.21M N/A | $331.26M 11.45% | $299.51M -9.58% | Avg: $468.88M Low: $462.67M High: $475.53M avg. 56.54% | |||
Net Income
% change YoY
| $-80.96M N/A | $-79.05M 2.36% | $-77.33M 2.17% | Avg: $-7.95M Low: $-6.55M High: $-6.55M avg. 89.71% | |||
EBITDA
% change YoY
| $-20.35M N/A | $-21.61M -6.21% | $-24.64M -13.99% | Avg: $-8.45M Low: $-8.34M High: $-8.57M avg. 65.67% | |||
EPS
% change YoY
| -$3.71 N/A | -$3.39 8.62% | -$3.18 6.19% | Avg: -$0.27 Low: -$0.27 High: -$0.27 avg. 91.50% | |||
Operating Expenses
% change YoY
| $150.14M N/A | $167.22M 11.37% | $123.29M -26.26% | Avg: $124.88M Low: $123.22M High: $126.65M avg. 1.28% | |||
FAQ
What is Tabula Rasa HealthCare stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 89.71% in 2025-2025.
We have gathered data from 1 analysts. Their low estimate is -6.55M, average is -7.95M and high is -6.55M.
What is Tabula Rasa HealthCare stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 56.54% in 2025-2025.
We have gathered data from 1 analysts. Their low revenue estimate is $462.67M, average is $468.88M and high is $475.53M.
What is Tabula Rasa HealthCare stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 91.50% in 2025-2025.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.27, average is -$0.27 and high is $-0.27.
What is the best performing analyst?
In the last twelve months analysts have been covering Tabula Rasa HealthCare stock. The most successful analyst is Vikram Kesavabhotla whose win rate is 100%. He has correctly predicted 1/1 price targets.